India
· Delayed Price · Currency is INR Eris Lifesciences Statistics
Total Valuation
NSE:ERIS has a market cap or net worth of INR 242.46 billion. The enterprise value is 269.13 billion.
| Market Cap | 242.46B |
| Enterprise Value | 269.13B |
Important Dates
The next estimated earnings date is Monday, August 4, 2025.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Feb 13, 2025 |
Share Statistics
NSE:ERIS has 136.20 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 136.20M |
| Shares Outstanding | 136.20M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 58.25% |
| Owned by Institutions (%) | 24.02% |
| Float | 43.82M |
Valuation Ratios
The trailing PE ratio is 68.97 and the forward PE ratio is 44.73. NSE:ERIS's PEG ratio is 1.36.
| PE Ratio | 68.97 |
| Forward PE | 44.73 |
| PS Ratio | 8.42 |
| PB Ratio | 7.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.64 |
| P/OCF Ratio | 22.77 |
| PEG Ratio | 1.36 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.46, with an EV/FCF ratio of 29.57.
| EV / Earnings | 76.49 |
| EV / Sales | 9.35 |
| EV / EBITDA | 26.46 |
| EV / EBIT | 38.35 |
| EV / FCF | 29.57 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.76.
| Current Ratio | 0.89 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 2.44 |
| Debt / FCF | 2.72 |
| Interest Coverage | 3.03 |
Financial Efficiency
Return on equity (ROE) is 11.54% and return on invested capital (ROIC) is 7.46%.
| Return on Equity (ROE) | 11.54% |
| Return on Assets (ROA) | 6.23% |
| Return on Invested Capital (ROIC) | 7.46% |
| Return on Capital Employed (ROCE) | 12.42% |
| Revenue Per Employee | 7.95M |
| Profits Per Employee | 971,934 |
| Employee Count | 3,620 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.73 |
Taxes
In the past 12 months, NSE:ERIS has paid 1.14 billion in taxes.
| Income Tax | 1.14B |
| Effective Tax Rate | 23.36% |
Stock Price Statistics
The stock price has increased by +62.50% in the last 52 weeks. The beta is -0.01, so NSE:ERIS's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | +62.50% |
| 50-Day Moving Average | 1,562.26 |
| 200-Day Moving Average | 1,392.40 |
| Relative Strength Index (RSI) | 54.44 |
| Average Volume (20 Days) | 405,040 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ERIS had revenue of INR 28.79 billion and earned 3.52 billion in profits. Earnings per share was 25.81.
| Revenue | 28.79B |
| Gross Profit | 21.65B |
| Operating Income | 7.02B |
| Pretax Income | 4.89B |
| Net Income | 3.52B |
| EBITDA | 10.17B |
| EBIT | 7.02B |
| Earnings Per Share (EPS) | 25.81 |
Balance Sheet
The company has 2.28 billion in cash and 24.78 billion in debt, giving a net cash position of -22.50 billion or -165.21 per share.
| Cash & Cash Equivalents | 2.28B |
| Total Debt | 24.78B |
| Net Cash | -22.50B |
| Net Cash Per Share | -165.21 |
| Equity (Book Value) | 32.72B |
| Book Value Per Share | 209.88 |
| Working Capital | -1.58B |
Cash Flow
In the last 12 months, operating cash flow was 10.65 billion and capital expenditures -1.55 billion, giving a free cash flow of 9.10 billion.
| Operating Cash Flow | 10.65B |
| Capital Expenditures | -1.55B |
| Free Cash Flow | 9.10B |
| FCF Per Share | 66.82 |
Margins
Gross margin is 75.20%, with operating and profit margins of 24.37% and 12.22%.
| Gross Margin | 75.20% |
| Operating Margin | 24.37% |
| Pretax Margin | 16.98% |
| Profit Margin | 12.22% |
| EBITDA Margin | 35.33% |
| EBIT Margin | 24.37% |
| FCF Margin | 31.61% |
Dividends & Yields
This stock pays an annual dividend of 7.35, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | 7.35 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 28.44% |
| Buyback Yield | -0.11% |
| Shareholder Yield | 0.34% |
| Earnings Yield | 1.45% |
| FCF Yield | 3.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |